Targeting of Herpes simplex virus to specific receptors

Details Targeting of Herpes simplex virus to specific receptors Targeting of Herpes simplex virus to specific receptors

2005-08-30

2009-06-23

Mosher, Mary E (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant virus encoding one or more heterologous proteins...

C424S093200, C424S231100, C435S235100, C435S320100

Reexamination Certificate

active

07550148

ABSTRACT:
The invention relates to engineered Herpes simplex virus (HSV) particles that are targeted to one or more specific binding pair members, such as receptors. Also, recombinant vectors for producing such HSV particles are provided. By reducing the affinity of HSV for its natural receptor(s) and increasing the affinity for a selected receptor, the HSV particles of the invention are useful for targeting cells that express the selected receptor, which itself may be a product of genetic engineering. The ability to selectively target cells renders the HSV particles particularly useful in selectively diagnosing, treating, and imaging cells bearing the selected binding pair member, such as a receptor. The invention also provides for polynucleotide-based therapy to cells bearing the selected binding pair member such as a receptor.

REFERENCES:
patent: 5599691 (1997-02-01), Roizman
patent: WO 99/06583 (1999-02-01), None
Debinski et al (Clinical Cancer Research 5: 985-990, 1999).
van Beusechem et al (Journal of Virology 76:2753-2762, Mar. 2002).
Connolly et al (Journal of Virology 77:8127-8140, 2003).
Latchman. Current Opinions in Molecular Therapeutics 7(5): 415-418, 2005.
Arsenakis, et al., J. Virol. 58(2):367-76 (1986).
Brooks, et al., Cell 79:1157-1164 (1994).
Brooks, et al., Science 264:569-571 (1994).
Brunetti, et al., J of Virol 72(4):3330-3339 (1998).
Burger, et al., Int. J. Cancer 100:228-237 (2002).
Campadelli-Fiume, et al., Reviews in Medical Virology 10:305-319 (2000).
Carfi, et al., Mol. Cell. 8(1):169-79 (2001).
Cassady, et al., J. Virol. 72(9):7005-11 (1998).
Chou, et al., Proc Natl Acad Sci USA 92(23):10516-20 (1995).
Cocchi, et al., J. Virol. 72:9992-10002 (1998).
Connolly,J. Virol, 79: 1282-1295 (2005).
Davis, et al., J. Neurosurg. 88:1-10 (1998).
Debinski, Crit. Rev. Oncogen 9:255-268 (1998).
Debinski, et al., Cancer Res. 5:985-990 (1999).
Debinski, et al., Clin. Cancer Res. 5(10 Suppl):3143s-3147s (1999).
Debinski, et al., Mol. Med. 6:440-449 (2000).
Ellerman, et al., Biochemistry 40:8930-8939 (2001).
Fracasso, et al., Prostate 53:9-23 (2002).
Genbitsky, et al., Peptides 23:97-102 A. (2001).
Hayashi, et al., Digestion 63:87-92 (2001).
He, et al., J. Virol. 71(8):6049-54 (1997).
Laquerre, et al. J. Virol. 72(7):6119-30 (1998).
Leib, et al., J. Exp. Med. 189:663-672 (1999).
Lorimer, et al., J Immunol Methods 237(1-2):147-57 (2000).
Mabjeesh, et al., Endo. Related Cancer 9:115-139 (2002).
Manoj et al.,Proc. Natl. Acad. Sci. USA. ,101: 12414-12421 (2004).
Markert, et al., Gene Ther. 7(10):867-74 (2000).
McKie, et al.,Neuropathol Appl Neurobiol. 24(5):367-72 (1998).
Mineta, et al., Nat Med., 1(9):938-43 (1995).
Mintz A., et al., Neoplasia 4:388-399 (2002).
Montgomery, et al., Cell 87:427-436 (1996).
Pyles, et al., Hum Gene Ther. 8(5):533-44 (1997).
Rampling, et al.,Gene Ther. 7(10):859-66 (2000).
Ross, et al., Cancer Res. 62:2546-2553 (2002).
Ruoslahti, E., Anu. Rev. Cell Dev. Biol. 12:697-715 (1996).
Sharma, et al., J Magn Reson Imaging 16(4):336-51 (2002).
Simard, et al., Virology 212(2):734-40 (1995).
Soling, et al., FEBS Lett. 527(1-3):153 (2002).
Spear, et al., Virology 275:1-9 (2000).
Thomas, et al., J. Clin. Oncol. 20:3213-3218 (2002).
Turner, et al., J of Virol 72(1): 873-75 (1998).
Urbanelli, et al., J Mol Biol. Nov 9:313(5):965-76 (2001).
Vries et al., “Positron Emission Tomography: Measurement of Transgene Expression”,Methods, 27(3): 234 (2002).
Vries, et al., Curr Pharm Des 8(16):1435-50 (2002).
Ye, et al., Proc. Natl. Acad. Sci. USA 97(20):11002-7 (2000).
Zago et al.,Proc. Natl. Acad. Sci. USA., 101: 17498-17503 (2004).
Zhou et al.,J. Virol, 9: 5272-5277 (2005).
Zhou, et al., J. Virol, 74(24):11782-91 (2000).
Zhou, et al., J. Virol. 75(13):6166-72 (2001).
Zhou, et al., J. Virol. 76(12):6197-204 (2002).

Affiliated with

Also associated with

Rating

Targeting of Herpes simplex virus to specific receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeting of Herpes simplex virus to specific receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting of Herpes simplex virus to specific receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4104238